XIZIMED successfully participated in the 93rd China International Exhibition on APIs, Intermediates, Packaging, and Equipment (API China), held at the Chongqing International Expo Center in China on November 12-14, 2025.

During the exhibition, XIZIMED not only attracted numerous existing and new partners from the manufacturers of APIs, Excipients and Packaging materials, and trading companies with its professional registration and compliance consulting services of APIs, Excipients and Packaging materials, but also garnered sustained attention from attendees. The booth remained bustling throughout the event, resulting in multiple preliminary cooperation agreements.

Li Yinbo, founder of XIZIMED, was also invited to share insights at the 9th IPEC China Conference on Pharmaceutical Excipients during this exhibition, presenting on A Brief Analysis of the Bundling Review of Pharmaceutical Excipients in China. The presentation delivered rich, detailed content and insightful perspectives, garnering high praise and lively discussions from attending industry experts, scholars, and corporate representatives. This sharing not only demonstrated XIZIMED 's specialized depth in its niche field but also advanced the industry's understanding and exchange regarding the bundling review system.

The successful participation in the 93rd API China has elevated XIZIMED's brand influence, professional expertise, and market expansion capabilities. We will remain committed to the core philosophy of providing the most professional and precise import/export registration and compliance consulting services for APIs, Excipients, and Packaging materials, while building the most time-consuming and effort-saving pathway to the market. We will continuously refine our service capabilities, collaborate with industry partners to navigate challenges amid transformation, seize opportunities for growth, and contribute our expertise and strength to advancing the high-quality and global development of China's pharmaceutical industry.